Celgene Corp (NASDAQ:CELG)

113.47
Delayed Data
As of Apr 17
 -2.89 / -2.48%
Today’s Change
68.38
Today|||52-Week Range
129.06
+1.44%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Celgene have a median target of 143.00, with a high estimate of 163.00 and a low estimate of 83.00. The median estimate represents a +26.02% increase from the last price of 113.47.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Buy stock in Celgene. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.06
Sales
$2.1B
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.68%
 
 
 
 
 
 
Growthannually 29.83%
 
 
 
 
 
 

Sales

Growthquarterly 1.45%
 
 
 
 
 
 
Growthannually 21.63%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account